Trials / Sponsors / Robert Lowsky
Robert Lowsky
Academic / Other · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes | Phase 2 | 2020-02-27 |
| Completed | TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1 Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma | Phase 1 / Phase 2 | 2016-11-07 |
| Completed | CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Tr Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia | Phase 2 | 2015-06-01 |
| Completed | A Phase I/II Study of Intratumoral Injection of SD-101 Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma | Phase 1 / Phase 2 | 2014-09-01 |
| Terminated | Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transp Lymphoma, Non-Hodgkin, Hodgkin Disease | Phase 1 | 2012-08-01 |
| Completed | Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Phase 1 | 2012-01-01 |